US FDA approves Mirum's drug for rare bone disorder
25/09/2026 19:57
US FDA approves Mirum's drug for rare bone disorder Sept 25 (Reuters) - The US Food and Drug Administration has approved Mirum Pharmaceuticals' MIRM.O drug to treat a rare bone disorder, the regulator said on Friday.
(Reporting by Kunal Das and Christy Santhosh in Bengaluru; Editing by Jonathan Ananda)
Recent news on Ipsen SA
See all newsHealth Rounds: New blood test matches gold standard for liver disease diagnosis
Brief: Ipsen Late-Breaking Data Raises Ambitions In PBC
Brief: Charles River Laboratories International Virtual Control Group To Be Used In Glp Study For Ipsen
Pharming shares rise after preliminary Q3 revenue beat
France's Ipsen Q3 sales rise 28% driven by core portfolio